Pharmaceutical Executive Daily: FDA Issues CRL to Elevar Therapeutics

July 13, 2026 1:36pm 2 min

In today's Pharmaceutical Executive Daily, a new industry analysis warns that direct-to-patient pharma platforms are scaling faster than the safety infrastructure needed to support them, FDA issues a complete response le...

Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena

July 10, 2026 11:43am 3 min

In today's Pharmaceutical Executive Daily, FDA quietly pauses its real-time public release of complete response letters, FDA approves Sanofi's Sarclisa Escena as the first anticancer treatment in the U.S. to be administe...

Pharmaceutical Executive Daily: FDA Approves Ennumo

July 09, 2026 12:13pm 4 min

In today's Pharmaceutical Executive Daily, FDA approves Ennumo, a pharma roundup covers Chemomab Therapeutics' merger with AI-enabled precision medicine company Scipher Medicine and Teva's global licensing agreement with...

Pharmaceutical Executive Daily: AI as Reinvention

July 08, 2026 2:25pm 3 min

“AI as Reinvention”: Transforming the Business of Medicine

July 08, 2026 8:00am 35 min

In this episode of the Pharm Exec podcast, Emmanuel Frenehard, executive vice president and chief digital officer at Sanofi, shares how one of the world's largest pharma companies is moving artificial intelligence from p...

Pharmaceutical Executive Daily: The Changing Reality of Pharmaceutical Commercialization

July 07, 2026 2:15pm 3 min

Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge

July 01, 2026 11:55am 3 min

In today's Pharmaceutical Executive Daily, AlzeCure Pharma announces a collaboration with QuantumCell ApS worth more than $2.2 billion for global rights to its Neurostore platform including Alzheimer's candidate ACD856, ...

Pharmaceutical Executive Daily: FDA Names Seven Participants to Precheck Program

June 30, 2026 11:04am 3 min

In today's Pharmaceutical Executive Daily, FDA selects seven companies for its new PreCheck Pilot Program, Kirsten Whipple examines how the concept of healthspan is emerging from academic obscurity into a powerful consum...

Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics

June 29, 2026 12:45pm 3 min

In today's Pharmaceutical Executive Daily, a pharma M&A roundup covers Ipsen's up to $1.75 billion acquisition of Kartos Therapeutics and Zymeworks' $929 million acquisition of Theravance Biopharma, Krista Pinto of Evers...

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

June 25, 2026 12:51pm 3 min

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

June 24, 2026 2:58pm 3 min

In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will leverage its early-stage drug discovery platform to advance targets sele...

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

June 23, 2026 2:50pm 3 min

In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timelines by six to 12 months as the US looks to reclaim its footing in glob...

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

June 22, 2026 1:58pm 3 min

In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding a suite of clinical-stage immunology assets to its portfolio, Insilico Medicine enters an AI-po...

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

June 19, 2026 11:02am 3 min

In today's Pharmaceutical Executive Daily, an FDA advisory committee votes unanimously in favor of the benefit-risk profile of Moderna's investigational mRNA-1010 seasonal influenza vaccine across both younger and older ...

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

June 18, 2026 1:51pm 3 min

In today's Pharmaceutical Executive Daily, Biogen announces its second acquisition of 2026, a deal worth up to $1 billion for private immunology biotech RayThera, FDA approves Utebzi as the first and only oral carbapenem...

Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs

June 17, 2026 12:05pm 3 min

In today's Pharmaceutical Executive Daily, FDA staff release briefing documents flagging evidence gaps in Moderna's mRNA flu vaccine, a pharma roundup covers Merck's $510 million collaboration with Protillion Biosciences...

Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm

June 16, 2026 2:10pm 4 min

In today's Pharmaceutical Executive Daily, Elicio Therapeutics shares tumble after its Phase II Amplifgy-7P trial of KRAS-targeting immunotherapy ELI-002 7P misses its primary endpoint in adjuvant pancreatic cancer, FDA ...

Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg

June 15, 2026 12:23pm 3 min

In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pharma regulatory roundup covers two significant FDA approvals, and Pharma...

Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO

June 12, 2026 11:34am 3 min

In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the cardiovascular biotech at approximately $1.3 billion, Pharmaceutical Executive speaks with Rick Winningham on bui...

Pharmaceutical Executive Daily: China's Latest Policy Guidance

June 11, 2026 1:46pm 3 min

In today's Pharmaceutical Executive Daily, Bruce Liu examines China's latest policy guidance establishing premium pricing and priority reimbursement access for truly innovative drugs, Parabilis Medicines surges more than...